Rhumbline Advisers Protara Therapeutics, Inc. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 31,541 shares of TARA stock, worth $153,920. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,541Holding current value
$153,920% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TARA
# of Institutions
82Shares Held
28MCall Options Held
37.2KPut Options Held
65.1K-
Janus Henderson Group PLC London, X04.1MShares$20 Million0.01% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA2.14MShares$10.4 Million11.14% of portfolio
-
Blackstone Inc New York, NY1.91MShares$9.32 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$8.79 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$8.55 Million3.47% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $55M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...